PRISM MEDICO AND PHARMACY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.96 INR | +2.32% |
|
-2.75% | -24.77% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 144.6 | 224.3 | 75.49 | 70.64 | 46.2 | 173.6 |
| Enterprise Value (EV) 1 | 152.8 | 243 | 74.37 | 69.8 | 45.65 | 172.6 |
| P/E ratio | -2,385 x | 558 x | -150 x | -54.3 x | -12.5 x | -220 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.63 x | 0.41 x | 0.28 x | 0.42 x | 0.55 x | 13.7 x |
| EV / Revenue | 0.67 x | 0.45 x | 0.28 x | 0.42 x | 0.54 x | 13.6 x |
| EV / EBITDA | 17.4 x | 139 x | -148 x | -42.9 x | -9.32 x | -181 x |
| EV / FCF | 4.79 x | -10 x | -1.14 x | 183 x | -2.57 x | -6.63 x |
| FCF Yield | 20.9% | -9.99% | -87.6% | 0.55% | -39% | -15.1% |
| Price to Book | 1.12 x | 1.74 x | 0.58 x | 0.55 x | 0.37 x | 1.14 x |
| Nbr of stocks (in thousands) | 6,063 | 6,063 | 6,063 | 6,063 | 6,063 | 6,063 |
| Reference price 2 | 23.85 | 37.00 | 12.45 | 11.65 | 7.620 | 28.63 |
| Announcement Date | 9/4/18 | 9/5/19 | 8/18/20 | 8/26/21 | 9/7/22 | 9/5/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 228 | 544.3 | 268.9 | 167.6 | 84.44 | 12.71 |
| EBITDA 1 | 8.777 | 1.745 | -0.5025 | -1.626 | -4.898 | -0.9539 |
| EBIT 1 | 4.312 | -2.082 | -0.6787 | -1.75 | -4.985 | -1.02 |
| Operating Margin | 1.89% | -0.38% | -0.25% | -1.04% | -5.9% | -8.03% |
| Earnings before Tax (EBT) 1 | 0.68 | -0.966 | -0.6812 | -1.752 | -4.989 | -1.023 |
| Net income 1 | -0.042 | 0.402 | -0.5025 | -1.3 | -3.699 | -0.7642 |
| Net margin | -0.02% | 0.07% | -0.19% | -0.78% | -4.38% | -6.01% |
| EPS 2 | -0.0100 | 0.0663 | -0.0829 | -0.2144 | -0.6100 | -0.1300 |
| Free Cash Flow 1 | 31.9 | -24.27 | -65.14 | 0.3823 | -17.8 | -26.04 |
| FCF margin | 13.99% | -4.46% | -24.23% | 0.23% | -21.08% | -204.94% |
| FCF Conversion (EBITDA) | 363.39% | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/4/18 | 9/5/19 | 8/18/20 | 8/26/21 | 9/7/22 | 9/5/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 8.19 | 18.6 | - | - | - | - |
| Net Cash position 1 | - | - | 1.12 | 0.84 | 0.55 | 0.96 |
| Leverage (Debt/EBITDA) | 0.9328 x | 10.68 x | - | - | - | - |
| Free Cash Flow 1 | 31.9 | -24.3 | -65.1 | 0.38 | -17.8 | -26 |
| ROE (net income / shareholders' equity) | -0.03% | 0.31% | -0.39% | -1% | -2.9% | -0.55% |
| ROA (Net income/ Total Assets) | 1.63% | -0.7% | -0.2% | -0.51% | -1.83% | -0.46% |
| Assets 1 | -2.576 | -57.16 | 253.6 | 256.4 | 202.5 | 167.7 |
| Book Value Per Share 2 | 21.20 | 21.30 | 21.50 | 21.30 | 20.70 | 25.00 |
| Cash Flow per Share 2 | 2.240 | 0.6700 | 0.1800 | 0.1400 | 0.0900 | 0.1600 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 9/4/18 | 9/5/19 | 8/18/20 | 8/26/21 | 9/7/22 | 9/5/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -24.77% | 1.63M | |
| +6.33% | 2.07B | |
| -11.17% | 1.74B | |
| +2.97% | 1.36B | |
| +18.59% | 1.26B | |
| -10.08% | 1.05B | |
| -11.28% | 989M | |
| -11.22% | 907M | |
| +19.56% | 821M | |
| +1.38% | 458M |
- Stock Market
- Equities
- PRISMMEDI6 Stock
- Financials Prism Medico and Pharmacy Limited